BCLC: Barcelona Clinic Liver Cancer; RFA: radiofrequency ablation therapy; TACE
: transarterial chemoembolization; TAE: transarterial embolization.
The immediate CT scan revealed that lipiodol was concentrated in the tumor and the effect of TACE
All patients underwent quadruple-phase MDCT (unenhanced, arterial, portal venous, delayed phases) before and after TACE
. MDCT images were obtained using a 64-row helical CT scanner) (SOMATOM Definition, Siemens Medical Solutions) with the following scanning protocol: tube voltage, 80-100 kVp; beam collimation, 14x1.2 mm; pitch, 0.6; tube current product value, 180 mAs; rotation time, 0.5 s.
= transcatheter arterial chemoembolization, RFA = radiofrequency ablation, Y-90 = yttrium-90 radioembolization, and SBRT = stereotactic body radiation therapy.
Five weeks after undergoing TACE
, he was readmitted with hematochezia and hemorrhagic shock.
Disinfection Process before and during TACE
For liver metastasis rupture during initial treatment, TACE
and HAIC with 5FU/ CDDP were performed for volume control.
Ermert, "In situ localization of TNF[alpha]/[beta], TACE
and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue," Cytokine, vol.
Variables AFP [greater AFP < 20 ng/ml P than or equal to] 20 ng/ml First-line chemotherapy regimens Platinum-based doublet 46 (62.2%) 156 (63.7%) regimen Taxane-based doublet 13 (17.6%) 44 (18.0%) regimen Triplet regimen 9 (12.2%) 17 (6.9%) 0.325 Single-drug regimen 6 (8.1%) 19 (7.8%) Others 0 (0.0%) 9 (3.7%) Response of first-line chemotherapy PR 28 (41.2%) 106 (56.1%) 0.024 SD + PD 40 (58.8%) 83 (43.9%) Subsequent therapies after the first-line chemo Second-line chemotherapy Yes 24 (40.0%) 97 (53.0%) 0.055 No 36 (60.0%) 86 (47.0%) Surgery treatment Yes 1 (1.4%) 8 (3.3%) 0.344 No 73 (98.6%) 237 (96.7%) Local treatment of LM (a) Yes 23 (31.1%) 60 (24.5%) 0.163 No 51 (68.9%) 185 (75.5%) (a) Including TACE
, ablation, radiotherapy, and liver resection.
AFP: Alpha-fetoprotein HCC: Hepatocellular carcinoma LT: Liver transplantation TACE
: Transarterial chemoembolization.
A 57-year-old male with a past medical history of cirrhosis and HCC secondary to chronic alcohol abuse and hepatitis C infection was undergoing serial transarterial chemoembolization (TACE
Most newly diagnosed HCC cases are at an intermediate advanced stage, and the therapeutic options are limited to palliative approaches using TACE
or chemotherapeutic agents [5, 40].